Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
05 2021
Historique:
received: 22 07 2020
accepted: 26 02 2021
pubmed: 10 4 2021
medline: 22 7 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

FOXP3 deficiency in mice and in patients with immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome results in fatal autoimmunity by altering regulatory T (T

Identifiants

pubmed: 33833438
doi: 10.1038/s41590-021-00910-8
pii: 10.1038/s41590-021-00910-8
pmc: PMC8173714
mid: NIHMS1678410
doi:

Substances chimiques

FOXP3 protein, human 0
Forkhead Transcription Factors 0
Foxp3 protein, mouse 0

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-619

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI153174
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI128976
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125603
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150686
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI085090
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116834
Pays : United States

Références

Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
pubmed: 22224781 pmcid: 6066374 doi: 10.1146/annurev.immunol.25.022106.141623
Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3
pubmed: 30784578 doi: 10.1016/j.immuni.2019.01.020
Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609–633 (2016).
pubmed: 27168246 pmcid: 4942112 doi: 10.1146/annurev-immunol-032712-095948
Hill, J. A. et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786–800 (2007).
pubmed: 18024188 doi: 10.1016/j.immuni.2007.09.010
Ferraro, A. et al. Interindividual variation in human T regulatory cells. Proc. Natl Acad. Sci. USA 111, E1111–E1120 (2014).
pubmed: 24610777 doi: 10.1073/pnas.1401343111 pmcid: 3970507
Zemmour, D. et al. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat. Immunol. 19, 291–301 (2018).
pubmed: 29434354 pmcid: 6069633 doi: 10.1038/s41590-018-0051-0
Ono, M. Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes. Immunology 160, 24–37 (2020).
pubmed: 32022254 pmcid: 7160660 doi: 10.1111/imm.13178
Kwon, H. K., Chen, H. M., Mathis, D. & Benoist, C. Different molecular complexes that mediate transcriptional induction and repression by FoxP3. Nat. Immunol. 18, 1238–1248 (2017).
pubmed: 28892470 pmcid: 5679728 doi: 10.1038/ni.3835
Campbell, D. J. & Koch, M. A. Phenotypical and functional specialization of FOXP3
pubmed: 21267013 pmcid: 3289970 doi: 10.1038/nri2916
Li, C. et al. TCR transgenic mice reveal stepwise, multi-site acquisition of the distinctive fat-Treg phenotype. Cell 174, 285–299 (2018).
pubmed: 29887374 pmcid: 6046274 doi: 10.1016/j.cell.2018.05.004
Dispirito, J. R. et al. Molecular diversification of regulatory T cells in nonlymphoid tissues. Sci. Immunol. 3, eaat5861 (2018).
pubmed: 30217811 pmcid: 6219455 doi: 10.1126/sciimmunol.aat5861
Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity 50, 493–504 (2019).
pubmed: 30737144 pmcid: 6382439 doi: 10.1016/j.immuni.2019.01.001
Powell, B. R., Buist, N. R. & Stenzel, P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100, 731–737 (1982).
pubmed: 7040622 doi: 10.1016/S0022-3476(82)80573-8
Ramsdell, F. & Ziegler, S. F. FOXP3 and scurfy: how it all began. Nat. Rev. Immunol. 14, 343–349 (2014).
pubmed: 24722479 doi: 10.1038/nri3650
Barzaghi, F., Passerini, L. & Bacchetta, R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front. Immunol. 3, 211 (2012).
pubmed: 23060872 pmcid: 3459184 doi: 10.3389/fimmu.2012.00211
d’Hennezel, E., Bin, D. K., Torgerson, T. & Piccirillo, C. A. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. J. Med. Genet. 49, 291–302 (2012).
pubmed: 22581967 doi: 10.1136/jmedgenet-2012-100759
Duclaux-Loras, R. et al. Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a French multicenter retrospective study. Clin. Transl. Gastroenterol. 9, 201 (2018).
pubmed: 30385752 pmcid: 6212456 doi: 10.1038/s41424-018-0064-x
Gambineri, E. et al. Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Front. Immunol. 9, 2411 (2018).
pubmed: 30443250 pmcid: 6223101 doi: 10.3389/fimmu.2018.02411
Barzaghi, F. et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J. Allergy Clin. Immunol. 141, 1036–1049 (2018).
pubmed: 29241729 doi: 10.1016/j.jaci.2017.10.041
Godfrey, V. L., Wilkinson, J. E. & Russell, L. B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379–1387 (1991).
pubmed: 2053595 pmcid: 1886400
Wan, Y. Y. & Flavell, R. A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766–770 (2007).
pubmed: 17220876 doi: 10.1038/nature05479
Van Gool, F. et al. A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells. Immunity 50, 362–377 (2019).
pubmed: 30709738 pmcid: 6476426 doi: 10.1016/j.immuni.2018.12.016
Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359–368 (2007).
pubmed: 17273171 doi: 10.1038/ni1445
Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007).
pubmed: 17220874 doi: 10.1038/nature05543
Charbonnier, L. M. et al. Functional reprogramming of regulatory T cells in the absence of Foxp3. Nat. Immunol. 20, 1208–1219 (2019).
pubmed: 31384057 pmcid: 6707855 doi: 10.1038/s41590-019-0442-x
Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713–1722 (2006).
pubmed: 16741580 pmcid: 1472239 doi: 10.1172/JCI25112
Otsubo, K. et al. Identification of FOXP3-negative regulatory T-like (CD4
pubmed: 21802372 doi: 10.1016/j.clim.2011.06.006
Boldt, A. et al. Differences in FOXP3 and CD127 expression in Treg-like cells in patients with IPEX syndrome. Clin. Immunol. 153, 109–111 (2014).
pubmed: 24727448 doi: 10.1016/j.clim.2014.04.001
Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4
pubmed: 14597769 doi: 10.1172/JCI19441
Gavin, M. A. et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl Acad. Sci. USA 103, 6659–6664 (2006).
pubmed: 16617117 doi: 10.1073/pnas.0509484103 pmcid: 1458937
Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. https://doi.org/10.1093/intimm/dxm014 (2007).
McMurchy, A. N. et al. A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells. Blood 121, 1265–1275 (2013).
pubmed: 23169781 doi: 10.1182/blood-2012-05-431023
Zemmour, D. et al. Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity. Proc. Natl Acad. Sci. USA 114, E3472–E3480 (2017).
pubmed: 28396406 doi: 10.1073/pnas.1700946114 pmcid: 5410798
Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693–1700 (2006).
pubmed: 16818676 pmcid: 2118333 doi: 10.1084/jem.20060468
Pesenacker, A. M. et al. A regulatory T-cell gene signature is a specific and sensitive biomarker to identify children with new-onset type 1 diabetes. Diabetes 65, 1031–1039 (2016).
pubmed: 26786322 doi: 10.2337/db15-0572
Stoeckius, M. et al. Cell hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).
pubmed: 30567574 pmcid: 6300015 doi: 10.1186/s13059-018-1603-1
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Bakke, A. C., Purtzer, M. Z. & Wildin, R. S. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). Clin. Exp. Immunol. 137, 373–378 (2004).
pubmed: 15270855 pmcid: 1809121 doi: 10.1111/j.1365-2249.2004.02537.x
Ziegler, S. F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209–226 (2006).
pubmed: 16551248 doi: 10.1146/annurev.immunol.24.021605.090547
Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4
pubmed: 12612578 doi: 10.1038/ni904
Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
pubmed: 12522256 doi: 10.1126/science.1079490
Malek, T. R. & Ashwell, J. D. Interleukin 2 upregulates expression of its receptor on a T cell clone. J. Exp. Med. 161, 1575–1580 (1985).
pubmed: 3925066 doi: 10.1084/jem.161.6.1575
Boyman, O. et al. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924–1927 (2006).
pubmed: 16484453 doi: 10.1126/science.1122927
Samstein, R. M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153–166 (2012).
pubmed: 23021222 pmcid: 3493256 doi: 10.1016/j.cell.2012.06.053
Remedios, K. A. et al. The TNFRSF members CD27 and OX40 coordinately limit T
pubmed: 30578350 doi: 10.1126/sciimmunol.aau2042
Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191–197 (2007).
pubmed: 17136045 doi: 10.1038/ni1428
Sitrin, J. et al. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J. Exp. Med. 210, 1153–1165 (2013).
pubmed: 23650440 pmcid: 3674700 doi: 10.1084/jem.20122248
Cobbold, S. & Waldmann, H. Infectious tolerance. Curr. Opin. Immunol. 10, 518–524 (1998).
pubmed: 9794831 doi: 10.1016/S0952-7915(98)80217-3
Plitas, G. et al. Regulatory T cells exhibit distinct features in human breast cancer. Immunity 45, 1122–1134 (2016).
pubmed: 27851913 pmcid: 5134901 doi: 10.1016/j.immuni.2016.10.032
Gambineri, E. et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J. Allergy Clin. Immunol. 122, 1105–1112 (2008).
pubmed: 18951619 doi: 10.1016/j.jaci.2008.09.027
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector T
pubmed: 16648838 doi: 10.1038/nature04753
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
pubmed: 24385147 doi: 10.1038/nprot.2014.006
Godec, J. et al. Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation. Immunity 44, 194–206 (2016).
pubmed: 26795250 pmcid: 5330663 doi: 10.1016/j.immuni.2015.12.006
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291 (2019).
pubmed: 30954476 pmcid: 6625319 doi: 10.1016/j.cels.2018.11.005
Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019).
pubmed: 30643263 pmcid: 6340744 doi: 10.1038/s41590-018-0276-y
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https://doi.org/10.1038/nbt.4314 (2018).
Klein, A. M. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187–1201 (2015).
pubmed: 26000487 pmcid: 4441768 doi: 10.1016/j.cell.2015.04.044
Johansen, N. & Quon, G. scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data. Genome Biol. 20, 166 (2019).
pubmed: 31412909 pmcid: 6693154 doi: 10.1186/s13059-019-1766-4
Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
pubmed: 24485249 pmcid: 4053721 doi: 10.1186/gb-2014-15-2-r29
Soneson, C. & Robinson, M. D. Bias, robustness and scalability in single-cell differential expression analysis. Nat. Methods 15, 255–261 (2018).
pubmed: 29481549 doi: 10.1038/nmeth.4612
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2009).

Auteurs

David Zemmour (D)

Department of Immunology, Harvard Medical School, Boston, MA, USA.
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Louis-Marie Charbonnier (LM)

Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Juliette Leon (J)

Department of Immunology, Harvard Medical School, Boston, MA, USA.
INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.

Emmanuelle Six (E)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.

Sevgi Keles (S)

Division of Pediatric Allergy and Immunology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Marianne Delville (M)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Mehdi Benamar (M)

Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Safa Baris (S)

Division of Pediatric Allergy and Immunology, Marmara University School of Medicine, Istanbul, Turkey.
Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Istanbul, Turkey.

Julien Zuber (J)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Karin Chen (K)

Division of Allergy and Immunology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
Division of Immunology, Department of Pediatrics, University of Washington and Seattle Children's Research Institute, Seattle, WA, USA.

Benedicte Neven (B)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Maria I Garcia-Lloret (MI)

Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Frank M Ruemmele (FM)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Carlo Brugnara (C)

Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Nadine Cerf-Bensussan (N)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Frederic Rieux-Laucat (F)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.

Marina Cavazzana (M)

Biotherapy Department and Clinical Investigation Center, Assistance Publique Hopitaux Paris, Inserm, Paris, France.
Université de Paris, Paris, France.
Institut Imagine, Paris, France.

Isabelle André (I)

INSERM UMR 1163, University of Paris, Imagine Institute, Paris, France.
Institut Imagine, Paris, France.

Talal A Chatila (TA)

Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Diane Mathis (D)

Department of Immunology, Harvard Medical School, Boston, MA, USA. cbdm@hms.harvard.edu.

Christophe Benoist (C)

Department of Immunology, Harvard Medical School, Boston, MA, USA. cbdm@hms.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH